Vocimagene amiretrorepvec with extended-release 5-fluorocytosine for treating recurrent high-grade glioma [ID1425]

  • In development
  • GID-TA10542
  • Expected publication date: TBC

Status:
In progress
Decision:
Prioritised
Process:
TA

Timeline

Key events during the development of the guidance:

Date Update
28 October 2019 In progress. Referred 31 July 2017
02 October 2019 Note added to the project documents

For further information on our processes and methods, please see our CHTE processes and methods manual